The rise in type 2 diabetes has become a significant public health concern in recent years. This form of diabetes happens when the body struggles to...

EGO's stock has been rising steadily and is approaching its 52-week high level. Let us find out whether it is too late to buy the stock.

Type 2 diabetes affects 1.2 million Australians and accounts for 85-90% of all diabetes cases. This chronic condition is characterised by high blood...

The EFF is at a crossroads. Following a bruising election and high-profile defections, the path it chooses at its December elective conference will...

Bajra, or pearl millet, is a highly nutritious grain that offers numerous health benefits, making it a significant addition to any diet. Here are some...

If you don't smoke, don't start. If you smoke, quit. If you don't quit, change. That is the message of Philip Morris International (PMI), the company...

High blood pressure is a well-known risk factor for heart disease and stroke, but recent research has uncovered another potential risk: weaker bones....

The National Blood Lead Level Survey Fact Sheet 2024 has revealed that items in and around households contain lead levels exceeding the threshold of...

After Accra Hearts of Oak's narrow 1-0 defeat to Bibiani Gold Stars, the club's Public Relations Officer, Kwame Opare Addo, called for calm...

EGO's Q3 results are likely to reflect higher gold prices and sales volumes. Let us determine whether you should add the stock to your portfolio now.